Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | TTR | P02766 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triaziquone SCHEMBL4879123 | 0.99 | TP53 (0.36) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL11350903 | 0.81 | HTT (0.42) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL5606305 | 0.81 | HTT (0.42) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL20771783 | 0.80 | ALDH1A1 (0.40) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL6387848 | 0.80 | MAPT (0.41) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL21358774 | 0.80 | MAPT (0.43) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL21409933 | 0.79 | DNMT1 (0.39) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL451592 | 0.79 | MAPT (0.40) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL33439 | 0.78 | HTT (0.42) | TP53MAPTSTAT3HTTSMN1; SMN2 | |
| Triaziquone SCHEMBL2063810 | 0.78 | MAPT (0.44) | TP53MAPTSTAT3HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200154713-A9 | ANTIMICROBIAL AND AGROCHEMICAL COMPOSITIONS | MYCO SCIENCES LIMITED (GB) | 2020-05-21 | — | — | US | disclosed |
| US-20190090492-A1 | ANTIMICROBIAL AND AGROCHEMICAL COMPOSITIONS | MYCO SCIENCES LIMITED (GB) | 2019-03-28 | — | — | US | disclosed |
| EP-3302064-A1 | ANTIMICROBIAL AND AGROCHEMICAL COMPOSITIONS | Myco Sciences Limited (GB) | 2018-04-11 | — | — | EP | disclosed |
| WO-2016200795-A1 | ANTIMICROBIAL AND AGROCHEMICAL COMPOSITIONS | MYCO SCIENCES LIMITED (GB) | 2016-12-15 | — | — | WO | disclosed |
| US-8076266-B2 | Urea phosphite fungicide | LIDOCHEM, INC. (US) | 2011-12-13 | — | — | US | disclosed |
| US-20090099021-A1 | Urea phosphite fungicide | LIDOCHEM LLC | 2009-04-16 | — | — | US | disclosed |
| US-20040035162-A1 | Fertiliser | MANDOPS (UK) LIMITED (GB) | 2004-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099021-A1 | Urea phosphite fungicide | PPA1, ACE, NUDT21 | TP53 1367/4885MAPT 344/4885STAT3 3985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.